Keywords: sanofi, nv1fgf, encouraging, ph, ii, french, drug

Sanofi's NV1FGF "encouraging" in Ph II

Article | 20 March 2006

Print This

French drug major Sanofi-Aventis has presented encouraging data from a Phase IIb trial of its angiogenesis product candidate NV1FGF, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in